A Five-miRNA Panel Identified From a Multicentric Case–control Study Serves as a Novel Diagnostic Tool for Ethnically Diverse Non-small-cell Lung Cancer Patients

Cheng Wang(Nanjing University), Chen‐Yu Zhang(Nanjing General Hospital of Nanjing Military Command), Yi Shen(Nanjing General Hospital of Nanjing Military Command), Sidi Chen(Yale Cancer Center), Ke Zen(Georgia State University), Xi Chen(Nanjing University), Nan Wang(Nanjing University), Xiangdong Wang(Shanghai Medical College of Fudan University), Junjun Wang(Nanjing General Hospital of Nanjing Military Command), Yanni Zhang(Jiangsu University), Anh Van Le(Ortho Clinical Diagnostics (United States)), Meng Ding(Hebei Medical University), Rafael W. Soto‐Gil(Ortho Clinical Diagnostics (United States)), Mingde Xia, Wanjian Gu(Nanjing University of Chinese Medicine)
EBioMedicine
August 6, 2015
10.1016/j.ebiom.2015.07.034
Cited by 85

Related Papers

CRISPR-Cas9 Knockin Mice for Genome Editing and Cancer Modeling
|Cell|2014|2k
Exogenous plant MIR168a specifically targets mammalian LDLRAP1: evidence of cross-kingdom regulation by microRNA
|Cell Research|2011|1.2k
Genome-wide CRISPR Screen in a Mouse Model of Tumor Growth and Metastasis
|Cell|2015|933
CRISPR-mediated direct mutation of cancer genes in the mouse liver
|Nature|2014|788
High-content CRISPR screening
|Nature Reviews Methods Primers|2022|572